nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramelteon—CYP1A2—Carmustine—brain cancer	0.298	0.351	CbGbCtD
Ramelteon—CYP3A4—Temozolomide—brain cancer	0.225	0.265	CbGbCtD
Ramelteon—CYP3A4—Lomustine—brain cancer	0.192	0.225	CbGbCtD
Ramelteon—CYP1A2—Etoposide—brain cancer	0.0884	0.104	CbGbCtD
Ramelteon—CYP3A4—Etoposide—brain cancer	0.0463	0.0545	CbGbCtD
Ramelteon—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00647	0.0464	CbGpPWpGaD
Ramelteon—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00589	0.0422	CbGpPWpGaD
Ramelteon—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00504	0.0362	CbGpPWpGaD
Ramelteon—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00502	0.036	CbGpPWpGaD
Ramelteon—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00459	0.0329	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—NTRK3—brain cancer	0.00378	0.0271	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—NTRK3—brain cancer	0.00378	0.0271	CbGpPWpGaD
Ramelteon—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.00311	0.0223	CbGpPWpGaD
Ramelteon—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.00299	0.0214	CbGpPWpGaD
Ramelteon—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.00242	0.0174	CbGpPWpGaD
Ramelteon—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.00233	0.0167	CbGpPWpGaD
Ramelteon—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00214	0.0153	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—PTCH2—brain cancer	0.00202	0.0145	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—PTCH2—brain cancer	0.00202	0.0145	CbGpPWpGaD
Ramelteon—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.00187	0.0134	CbGpPWpGaD
Ramelteon—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.0018	0.0129	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—OR14C36—brain cancer	0.00177	0.0127	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—OR4C12—brain cancer	0.00177	0.0127	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—OR14C36—brain cancer	0.00177	0.0127	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—OR4C12—brain cancer	0.00177	0.0127	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—OR4C12—brain cancer	0.00161	0.0115	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—OR4C12—brain cancer	0.00161	0.0115	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—OR14C36—brain cancer	0.00161	0.0115	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—OR14C36—brain cancer	0.00161	0.0115	CbGpPWpGaD
Ramelteon—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00159	0.0114	CbGpPWpGaD
Ramelteon—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00149	0.0107	CbGpPWpGaD
Ramelteon—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00129	0.00926	CbGpPWpGaD
Ramelteon—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00128	0.00921	CbGpPWpGaD
Ramelteon—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00127	0.00914	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—SIRT1—brain cancer	0.00125	0.00899	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—SIRT1—brain cancer	0.00125	0.00899	CbGpPWpGaD
Ramelteon—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00122	0.00877	CbGpPWpGaD
Ramelteon—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00116	0.00835	CbGpPWpGaD
Ramelteon—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00105	0.00751	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—SHH—brain cancer	0.00104	0.00746	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—SHH—brain cancer	0.00104	0.00746	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—PTCH2—brain cancer	0.00104	0.00743	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—PTCH2—brain cancer	0.00104	0.00743	CbGpPWpGaD
Ramelteon—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00101	0.00722	CbGpPWpGaD
Ramelteon—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000993	0.00712	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—PTCH1—brain cancer	0.000986	0.00707	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—SMO—brain cancer	0.000986	0.00707	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—SMO—brain cancer	0.000986	0.00707	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—PTCH1—brain cancer	0.000986	0.00707	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—OR14C36—brain cancer	0.00095	0.00681	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—OR14C36—brain cancer	0.00095	0.00681	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—OR4C12—brain cancer	0.00095	0.00681	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—OR4C12—brain cancer	0.00095	0.00681	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—CDK4—brain cancer	0.000949	0.0068	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—CDK4—brain cancer	0.000949	0.0068	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—ABR—brain cancer	0.000896	0.00642	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—ABR—brain cancer	0.000896	0.00642	CbGpPWpGaD
Ramelteon—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000816	0.00585	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—ABR—brain cancer	0.000813	0.00583	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—ABR—brain cancer	0.000813	0.00583	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—DTX2—brain cancer	0.000808	0.00579	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—DTX2—brain cancer	0.000808	0.00579	CbGpPWpGaD
Ramelteon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000777	0.00557	CbGpPWpGaD
Ramelteon—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000767	0.0055	CbGpPWpGaD
Ramelteon—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.00066	0.00473	CbGpPWpGaD
Ramelteon—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00063	0.00451	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PTCH2—brain cancer	0.000612	0.00439	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PTCH2—brain cancer	0.000612	0.00439	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HES5—brain cancer	0.000593	0.00425	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HES5—brain cancer	0.000593	0.00425	CbGpPWpGaD
Ramelteon—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000585	0.00419	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—STRADA—brain cancer	0.000576	0.00413	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—STRADA—brain cancer	0.000576	0.00413	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—TRPC6—brain cancer	0.000567	0.00406	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—TRPC6—brain cancer	0.000567	0.00406	CbGpPWpGaD
Ramelteon—Thinking abnormal—Carmustine—brain cancer	0.000562	0.0514	CcSEcCtD
Ramelteon—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000556	0.00399	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000549	0.00393	CbGpPWpGaD
Ramelteon—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000537	0.00385	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—SHH—brain cancer	0.000534	0.00383	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—SHH—brain cancer	0.000534	0.00383	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—TRPC6—brain cancer	0.000515	0.00369	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—TRPC6—brain cancer	0.000515	0.00369	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—PTCH1—brain cancer	0.000506	0.00363	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—PTCH1—brain cancer	0.000506	0.00363	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—SMO—brain cancer	0.000506	0.00363	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—SMO—brain cancer	0.000506	0.00363	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—ABR—brain cancer	0.00048	0.00344	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—ABR—brain cancer	0.00048	0.00344	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—GLI2—brain cancer	0.000464	0.00333	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—GLI2—brain cancer	0.000464	0.00333	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000447	0.0032	CbGpPWpGaD
Ramelteon—Mental disability—Carmustine—brain cancer	0.000446	0.0409	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—GLI1—brain cancer	0.000436	0.00313	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—GLI1—brain cancer	0.000436	0.00313	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000433	0.00311	CbGpPWpGaD
Ramelteon—Mental disability—Temozolomide—brain cancer	0.000431	0.0395	CcSEcCtD
Ramelteon—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000427	0.00306	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—VAV1—brain cancer	0.000425	0.00304	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—VAV1—brain cancer	0.000425	0.00304	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—SUFU—brain cancer	0.000414	0.00296	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—SUFU—brain cancer	0.000414	0.00296	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—TP53—brain cancer	0.000404	0.00289	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—TP53—brain cancer	0.000404	0.00289	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—GFAP—brain cancer	0.000399	0.00286	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—GFAP—brain cancer	0.000399	0.00286	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—VAV1—brain cancer	0.000386	0.00277	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—VAV1—brain cancer	0.000386	0.00277	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HEY1—brain cancer	0.000378	0.00271	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HEY1—brain cancer	0.000378	0.00271	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—DLL1—brain cancer	0.000371	0.00266	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—DLL1—brain cancer	0.000371	0.00266	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000334	0.0024	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.00033	0.00236	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—SHH—brain cancer	0.000315	0.00226	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—SHH—brain cancer	0.000315	0.00226	CbGpPWpGaD
Ramelteon—Arthralgia—Procarbazine—brain cancer	0.000306	0.028	CcSEcCtD
Ramelteon—Myalgia—Procarbazine—brain cancer	0.000306	0.028	CcSEcCtD
Ramelteon—MTNR1B—Signaling Pathways—TRPC6—brain cancer	0.000304	0.00218	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TRPC6—brain cancer	0.000304	0.00218	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—SMO—brain cancer	0.000299	0.00214	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PTCH1—brain cancer	0.000299	0.00214	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PTCH1—brain cancer	0.000299	0.00214	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—SMO—brain cancer	0.000299	0.00214	CbGpPWpGaD
Ramelteon—Anaphylactoid reaction—Etoposide—brain cancer	0.000298	0.0273	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Temozolomide—brain cancer	0.00029	0.0265	CcSEcCtD
Ramelteon—Depression—Carmustine—brain cancer	0.000287	0.0263	CcSEcCtD
Ramelteon—Depression—Temozolomide—brain cancer	0.000277	0.0254	CcSEcCtD
Ramelteon—Nausea—Lomustine—brain cancer	0.000274	0.0251	CcSEcCtD
Ramelteon—MTNR1A—GPCR downstream signaling—PIK3CG—brain cancer	0.00027	0.00193	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—PIK3CG—brain cancer	0.00027	0.00193	CbGpPWpGaD
Ramelteon—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000267	0.0245	CcSEcCtD
Ramelteon—Insomnia—Procarbazine—brain cancer	0.000265	0.0243	CcSEcCtD
Ramelteon—Somnolence—Procarbazine—brain cancer	0.000261	0.0239	CcSEcCtD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000258	0.00185	CbGpPWpGaD
Ramelteon—Fatigue—Procarbazine—brain cancer	0.000253	0.0232	CcSEcCtD
Ramelteon—MTNR1B—Signaling by GPCR—PIK3CG—brain cancer	0.000245	0.00176	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—PIK3CG—brain cancer	0.000245	0.00176	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NOTCH2—brain cancer	0.000239	0.00171	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NOTCH2—brain cancer	0.000239	0.00171	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000232	0.00167	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—VAV1—brain cancer	0.000228	0.00163	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—VAV1—brain cancer	0.000228	0.00163	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000214	0.00153	CbGpPWpGaD
Ramelteon—Dysgeusia—Temozolomide—brain cancer	0.000213	0.0195	CcSEcCtD
Ramelteon—Asthenia—Procarbazine—brain cancer	0.00021	0.0193	CcSEcCtD
Ramelteon—Somnolence—Hydroxyurea—brain cancer	0.000202	0.0185	CcSEcCtD
Ramelteon—Diarrhoea—Procarbazine—brain cancer	0.000201	0.0184	CcSEcCtD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000197	0.00142	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HES1—brain cancer	0.000196	0.0014	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HES1—brain cancer	0.000196	0.0014	CbGpPWpGaD
Ramelteon—Fatigue—Hydroxyurea—brain cancer	0.000196	0.0179	CcSEcCtD
Ramelteon—Dizziness—Procarbazine—brain cancer	0.000194	0.0178	CcSEcCtD
Ramelteon—Myalgia—Carmustine—brain cancer	0.000191	0.0175	CcSEcCtD
Ramelteon—MTNR1A—GPCR downstream signaling—IL2—brain cancer	0.00019	0.00136	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—IL2—brain cancer	0.00019	0.00136	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PDGFRA—brain cancer	0.000187	0.00134	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PDGFRA—brain cancer	0.000187	0.00134	CbGpPWpGaD
Ramelteon—Myalgia—Temozolomide—brain cancer	0.000185	0.0169	CcSEcCtD
Ramelteon—Arthralgia—Temozolomide—brain cancer	0.000185	0.0169	CcSEcCtD
Ramelteon—Headache—Procarbazine—brain cancer	0.000184	0.0168	CcSEcCtD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000182	0.0013	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—SPP1—brain cancer	0.000181	0.0013	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—SPP1—brain cancer	0.000181	0.0013	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000178	0.00127	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000178	0.00127	CbGpPWpGaD
Ramelteon—Anaphylactic shock—Temozolomide—brain cancer	0.000177	0.0162	CcSEcCtD
Ramelteon—Nausea—Procarbazine—brain cancer	0.000174	0.016	CcSEcCtD
Ramelteon—MTNR1B—Signaling by GPCR—IL2—brain cancer	0.000172	0.00124	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—IL2—brain cancer	0.000172	0.00124	CbGpPWpGaD
Ramelteon—Dysgeusia—Etoposide—brain cancer	0.00017	0.0156	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Carmustine—brain cancer	0.000167	0.0153	CcSEcCtD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000166	0.00119	CbGpPWpGaD
Ramelteon—Insomnia—Carmustine—brain cancer	0.000166	0.0152	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—IRS2—brain cancer	0.000164	0.00117	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IRS2—brain cancer	0.000164	0.00117	CbGpPWpGaD
Ramelteon—Somnolence—Carmustine—brain cancer	0.000163	0.0149	CcSEcCtD
Ramelteon—Asthenia—Hydroxyurea—brain cancer	0.000163	0.0149	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000162	0.0148	CcSEcCtD
Ramelteon—Insomnia—Temozolomide—brain cancer	0.00016	0.0147	CcSEcCtD
Ramelteon—Somnolence—Temozolomide—brain cancer	0.000158	0.0144	CcSEcCtD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000156	0.00112	CbGpPWpGaD
Ramelteon—Diarrhoea—Hydroxyurea—brain cancer	0.000155	0.0142	CcSEcCtD
Ramelteon—Fatigue—Temozolomide—brain cancer	0.000153	0.014	CcSEcCtD
Ramelteon—Dizziness—Hydroxyurea—brain cancer	0.00015	0.0137	CcSEcCtD
Ramelteon—MTNR1B—Signaling Pathways—APC—brain cancer	0.000145	0.00104	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PIK3CG—brain cancer	0.000145	0.00104	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—APC—brain cancer	0.000145	0.00104	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PIK3CG—brain cancer	0.000145	0.00104	CbGpPWpGaD
Ramelteon—Headache—Hydroxyurea—brain cancer	0.000142	0.013	CcSEcCtD
Ramelteon—Anaphylactic shock—Etoposide—brain cancer	0.000142	0.013	CcSEcCtD
Ramelteon—Nausea—Hydroxyurea—brain cancer	0.000135	0.0123	CcSEcCtD
Ramelteon—MTNR1B—Signaling by GPCR—EGFR—brain cancer	0.000132	0.000945	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—EGFR—brain cancer	0.000132	0.000945	CbGpPWpGaD
Ramelteon—Asthenia—Carmustine—brain cancer	0.000132	0.0121	CcSEcCtD
Ramelteon—Asthenia—Temozolomide—brain cancer	0.000127	0.0116	CcSEcCtD
Ramelteon—Somnolence—Etoposide—brain cancer	0.000126	0.0115	CcSEcCtD
Ramelteon—Diarrhoea—Carmustine—brain cancer	0.000126	0.0115	CcSEcCtD
Ramelteon—Fatigue—Etoposide—brain cancer	0.000122	0.0112	CcSEcCtD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000122	0.000872	CbGpPWpGaD
Ramelteon—Dizziness—Carmustine—brain cancer	0.000121	0.0111	CcSEcCtD
Ramelteon—Diarrhoea—Temozolomide—brain cancer	0.000121	0.0111	CcSEcCtD
Ramelteon—Dizziness—Temozolomide—brain cancer	0.000117	0.0107	CcSEcCtD
Ramelteon—Headache—Carmustine—brain cancer	0.000115	0.0105	CcSEcCtD
Ramelteon—MTNR1B—Signaling Pathways—RELA—brain cancer	0.000113	0.00081	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—RELA—brain cancer	0.000113	0.00081	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—ERBB2—brain cancer	0.000112	0.000805	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—ERBB2—brain cancer	0.000112	0.000805	CbGpPWpGaD
Ramelteon—Headache—Temozolomide—brain cancer	0.000111	0.0102	CcSEcCtD
Ramelteon—Nausea—Carmustine—brain cancer	0.000109	0.00998	CcSEcCtD
Ramelteon—Nausea—Temozolomide—brain cancer	0.000105	0.00964	CcSEcCtD
Ramelteon—MTNR1B—Signaling Pathways—IL2—brain cancer	0.000102	0.00073	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IL2—brain cancer	0.000102	0.00073	CbGpPWpGaD
Ramelteon—Asthenia—Etoposide—brain cancer	0.000102	0.00932	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—CCND1—brain cancer	9.92e-05	0.000711	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCND1—brain cancer	9.92e-05	0.000711	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CTNNB1—brain cancer	9.83e-05	0.000705	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CTNNB1—brain cancer	9.83e-05	0.000705	CbGpPWpGaD
Ramelteon—Diarrhoea—Etoposide—brain cancer	9.71e-05	0.00889	CcSEcCtD
Ramelteon—CYP2C19—Metabolism—CYP2C9—brain cancer	9.51e-05	0.000682	CbGpPWpGaD
Ramelteon—Dizziness—Etoposide—brain cancer	9.38e-05	0.00859	CcSEcCtD
Ramelteon—Headache—Etoposide—brain cancer	8.89e-05	0.00814	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—VEGFA—brain cancer	8.65e-05	0.00062	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—VEGFA—brain cancer	8.65e-05	0.00062	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—STAT3—brain cancer	8.57e-05	0.000614	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—STAT3—brain cancer	8.57e-05	0.000614	CbGpPWpGaD
Ramelteon—Nausea—Etoposide—brain cancer	8.43e-05	0.00772	CcSEcCtD
Ramelteon—CYP2C19—Metabolism—BSG—brain cancer	8.09e-05	0.00058	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MYC—brain cancer	7.96e-05	0.000571	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MYC—brain cancer	7.96e-05	0.000571	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—EGFR—brain cancer	7.79e-05	0.000558	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—EGFR—brain cancer	7.79e-05	0.000558	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP2C9—brain cancer	7.41e-05	0.000531	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—IDH1—brain cancer	6.96e-05	0.000499	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TP53—brain cancer	6.54e-05	0.000469	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TP53—brain cancer	6.54e-05	0.000469	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—BSG—brain cancer	6.3e-05	0.000452	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP2C9—brain cancer	5.72e-05	0.00041	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.66e-05	0.000406	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ENO2—brain cancer	5.5e-05	0.000394	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—IDH1—brain cancer	5.42e-05	0.000389	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—BSG—brain cancer	4.86e-05	0.000349	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.41e-05	0.000316	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ENO2—brain cancer	4.28e-05	0.000307	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—IDH1—brain cancer	4.18e-05	0.0003	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ENO2—brain cancer	3.31e-05	0.000237	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CG—brain cancer	2.52e-05	0.000181	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CG—brain cancer	1.97e-05	0.000141	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CG—brain cancer	1.52e-05	0.000109	CbGpPWpGaD
